Form 4: uniQure N.V. Executive Pierre Caloz Sells Shares to Cover Tax Obligations

Chief Operating Officer Pierre Caloz sold 2,936 ordinary shares of uniQure N.V. to cover withholding taxes upon the vesting of restricted share units.

Summary

• On June 17, 2024, Pierre Caloz, the Chief Operating Officer of uniQure N.V., sold 2,936 ordinary shares.
• The sale was executed to cover estimated withholding taxes associated with the vesting of restricted share units.
• The shares were sold at a weighted average price of $4.81, with individual transactions ranging from $4.78 to $4.83.
• Following the transaction, Caloz beneficially owns 115,707 ordinary shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The transaction is a routine sale of shares to cover tax obligations, which doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

This transaction is a routine sale of shares by an executive to cover tax obligations, which is a common practice among company executives who receive stock-based compensation. It doesn't necessarily reflect a change in the executive's confidence in the company's future prospects.

Comparison to Industry Standards

• Sales of shares to cover tax obligations are a common practice among executives at publicly traded companies, including those in the biotechnology sector like Amgen (AMGN), Gilead Sciences (GILD), and Biogen (BIIB).
• These companies' executives often execute similar transactions following the vesting of restricted stock units.
• The size of the sale (2,936 shares) is relatively small compared to the total shares beneficially owned (115,707), suggesting it's primarily for tax purposes rather than a significant divestment.

Stakeholder Impact

• The sale of shares may have a minimal impact on shareholders, as it's a small transaction by an individual executive.
• Employees are unlikely to be directly affected by this transaction.

Key Dates